These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12789132)

  • 1. The retained placenta.
    Weeks AD
    Afr Health Sci; 2001 Aug; 1(1):36-41. PubMed ID: 12789132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical vein injection for management of retained placenta.
    Kumar N; Jahanfar S; Haas DM; Weeks AD
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001337. PubMed ID: 33705565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2001; (4):CD001337. PubMed ID: 11687109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical vein injection for management of retained placenta.
    Nardin JM; Weeks A; Carroli G
    Cochrane Database Syst Rev; 2011 May; (5):CD001337. PubMed ID: 21563129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
    Weeks AD; Alia G; Vernon G; Namayanja A; Gosakan R; Majeed T; Hart A; Jafri H; Nardin J; Carroli G; Fairlie F; Raashid Y; Mirembe F; Alfirevic Z
    Lancet; 2010 Jan; 375(9709):141-7. PubMed ID: 20004013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-umbilical vein injection of carbetocin versus oxytocin in the management of retained placenta.
    Salem MAA; Saraya YS; Badr MS; Soliman AM
    Sex Reprod Healthc; 2019 Oct; 21():21-25. PubMed ID: 31395229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial.
    Gazvani MR; Luckas MJ; Drakeley AJ; Emery SJ; Alfirevic Z; Walkinshaw SA
    Obstet Gynecol; 1998 Feb; 91(2):203-7. PubMed ID: 9469276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retained placenta.
    Weeks AD
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1103-17. PubMed ID: 18793876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Grupo Argentino de Estudio de Placenta Retenida.
    Carroli G; Belizan JM; Grant A; Gonzalez L; Campodonico L; Bergel E
    Br J Obstet Gynaecol; 1998 Feb; 105(2):179-85. PubMed ID: 9501783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?
    Lim PS; Singh S; Lee A; Muhammad Yassin MA
    Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical oxytocin injection for the treatment of retained placentas.
    Weeks AD
    Trop Doct; 2003 Jul; 33(3):162-3. PubMed ID: 12870604
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a retained placenta with intraumbilical oxytocin injection.
    Habek D; Hrgović Z; Ivanisević M; Delmis J
    Zentralbl Gynakol; 2001 Jul; 123(7):415-7. PubMed ID: 11534303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2000; (2):CD001337. PubMed ID: 10796259
    [No Abstract]   [Full Text] [Related]  

  • 15. Umbilical vein injection for the routine management of third stage of labour.
    Mori R; Nardin JM; Yamamoto N; Carroli G; Weeks A
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006176. PubMed ID: 22419311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
    Huber MG; Wildschut HI; Boer K; Kleiverda G; Hoek FJ
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1216-9. PubMed ID: 1709781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.
    Soltani H; Hutchon DR; Poulose TA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006173. PubMed ID: 20687079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour.
    Abedi P; Jahanfar S; Namvar F; Lee J
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010845. PubMed ID: 26816300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.